EUVIMEDEUVIMED entdecken
Vergleichsstudie

Superiority of long axial field-of-view 68Ga-PSMA-11 PET over short axial field-of-view PET in prostate cancer: a head-to-head comparison

Yining Wang, Lijing Zhu, Lian Xu, Liang Dong, Haitao Zhao, Lianghua Li, Gang Huang iD, Ruohua Chen, Jianjun Liu

European Journal of Nuclear Medicine and Molecular Imaging · 2026

DOI: 10.1007/s00259-025-07546-y ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Yining Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, 201800, Shanghai, Chi…. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Positron Emission Tomography Computed Tomography, Edetic Acid, Oligopeptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND PURPOSE: Previous studies have shown that long axial field-of-view (LAFOV) 68Ga-PSMA-11 PET/CT can significantly improve the detection rate compared to short axial field-of-view (SAFOV) 68Ga-PSMA-11 PET/CT in prostate cancer. However, the diagnostic efficiency between the two scans was compared in different cohorts, not directly within the same patients. Whether LAFOV 68Ga-PSMA-11 PET could improve image quality, enhance lesion quantification, and impact patient treatment decisions in the same patients remains unclear. To address this research gap, we performed a direct comparison of LAFOV and SAFOV 68Ga-PSMA-11 PET in the same cohort of prostate cancer patients to evaluate whether LAFOV 68Ga-PSMA-11 PET could enhance lesion identification and modify clinical management compared to SAFOV 68Ga-PSMA-11 PET. METHODS: Thirty-four patients with prostate cancer undergoing routine 68Ga-PSMA-11 PET/CT were included and underwent a same-day dual-scanning protocol. Half of the patients first underwent a clinically routine SAFOV PET scan using continuous bed motion, followed immediately by LAFOV PET (5-minute acquisition in list mode); the other half underwent scanning in the reverse order. The image quality of LAFOV and SAFOV 68Ga-PSMA-11 PET was compared using subjective scoring and objective parameters. Objective parameters, including maximum and mean standardized uptake values (SUVmax and SUVmean), signal-to-noise ratio (SNR), and tumor-to-background ratio (TBR), were measured and compared. RESULTS: LAFOV 68Ga-PSMA-11 PET exhibited superior image quality compared to SAFOV PET based on both subjective and objective parameters. LAFOV 68Ga-PSMA-11 PET had better image quality and higher lesion SUVmax, SNR, and TBR compared to SAFOV PET. In 17.65% of patients, LAFOV 68Ga-PSMA-11 PET detected additional lesions that were unidentified on SAFOV 68Ga-PSMA-11 PET. Compared to SAFOV 68Ga-PSMA-11 PET, LAFOV 68Ga-PSMA-11 PET detected additional lesions in 33.33% of patients with biochemical recurrence and 9.09% of patients with newly diagnosed prostate cancer, leading to significant changes in clinical management. CONCLUSIONS: In this head-to-head comparison, LAFOV 68Ga-PSMA-11 PET demonstrated superior image quality, enhanced lesion detection, and a significant impact on clinical management for both biochemical recurrence and newly diagnosed prostate cancer patients compared to SAFOV 68Ga-PSMA-11 PET. These findings suggest that LAFOV 68Ga-PSMA-11 PET may be the preferred imaging modality for comprehensive prostate cancer evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsPositron Emission Tomography Computed TomographyEdetic AcidOligopeptidesHumansMaleGallium RadioisotopesGallium IsotopesAgedMiddle AgedAged, 80 and over

Stichwörter der Autor:innen

Detection rateLAFOV 68Ga-PSMA-11 PETManagementProstate cancer

Substanzen

gallium 68 PSMA-11Gallium RadioisotopesGallium IsotopesEdetic AcidOligopeptides

Autor:innen und Institutionen

  • Department of Nuclear Medicine, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, 201800, Shanghai, China.
  • Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 200127, Shanghai, China.
  • Department of Emergency and Critical Care Medicine, Shanghai General Hospital (Shanghai First People's Hospital), Shanghai Jiao Tong University School of Medicine, 200080, Shanghai, China.
  • Department of Urology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 200127, Shanghai, China.
  • Department of Nuclear Medicine, Jiading District Central Hospital Affiliated Shanghai University of Medicine & Health Sciences, 201800, Shanghai, China. huang2802@163.com.
  • Department of Nuclear Medicine, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, 200127, Shanghai, China. huang2802@163.com.

ORCID-Profile: Gang Huang

Zitieren

APA

Wang, Y., Zhu, L., Xu, L., Dong, L., Zhao, H., Li, L., Huang, G., Chen, R., & Liu, J. (2026). Superiority of long axial field-of-view 68Ga-PSMA-11 PET over short axial field-of-view PET in prostate cancer: a head-to-head comparison. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07546-y

Vancouver

Wang Y, Zhu L, Xu L, Dong L, Zhao H, Li L, et al. Superiority of long axial field-of-view 68Ga-PSMA-11 PET over short axial field-of-view PET in prostate cancer: a head-to-head comparison. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-025-07546-y

BibTeX
@article{Wang2026,
  author = {Wang, Yining and Zhu, Lijing and Xu, Lian and Dong, Liang and Zhao, Haitao and Li, Lianghua and Huang, Gang and Chen, Ruohua and Liu, Jianjun},
  title = {Superiority of long axial field-of-view 68Ga-PSMA-11 PET over short axial field-of-view PET in prostate cancer: a head-to-head comparison},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  doi = {10.1007/s00259-025-07546-y}
}
Kostenlos starten →